Alliance for Cannabis Therapeutics
Alliance for Cannabis Therapeutics[edit]

The Alliance for Cannabis Therapeutics (ACT) is an organization dedicated to advocating for the medical use of cannabis and influencing cannabis law reform. Founded in the late 20th century, the ACT has played a pivotal role in raising awareness about the therapeutic benefits of cannabis and supporting patients' rights to access cannabis-based treatments.
History[edit]
The Alliance for Cannabis Therapeutics was established in response to growing evidence and patient testimonials regarding the medicinal properties of cannabis. During a time when cannabis was largely prohibited, the ACT emerged as a voice for patients who found relief from various conditions through cannabis use. The organization has been instrumental in lobbying for changes in legislation to allow for the medical use of cannabis.
Mission and Goals[edit]
The primary mission of the ACT is to promote the acceptance of cannabis as a legitimate therapeutic option. The organization aims to:
- Advocate for the legal recognition of cannabis as a medicine.
- Support scientific research into the medical benefits of cannabis.
- Educate the public and policymakers about the therapeutic uses of cannabis.
- Protect the rights of patients to access cannabis-based treatments.
Activities[edit]
The Alliance for Cannabis Therapeutics engages in various activities to achieve its goals, including:
- Lobbying and Advocacy: ACT works with lawmakers and government agencies to influence cannabis policy and legislation.
- Public Education: The organization conducts seminars, workshops, and public campaigns to inform the public about the medical uses of cannabis.
- Research Support: ACT supports and collaborates with researchers to advance scientific understanding of cannabis and its therapeutic potential.
Impact[edit]
The efforts of the Alliance for Cannabis Therapeutics have contributed significantly to the shift in public perception and policy regarding medical cannabis. The organization's advocacy has helped pave the way for the legalization of medical cannabis in several jurisdictions, providing patients with access to alternative treatments.
Related Pages[edit]
| Cannabis | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
*
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian